StockWatch
·

KILBURN ENGINEERING LTD. Q1 FY27 Results

KLBRENG-BQ1 FY27 Results
Filing
Result:Weak· Market: DownMargin squeeze
MetricValueQ4 FY26Q1 FY26
Revenue116.99 Cr38.2%9.5%
Total Income120.52 Cr38.7%8.5%
Expenditure102.98 Cr35.5%0.8%
PBT17.55 Cr52.6%40.8%
Net Profit13.09 Cr47.3%38.6%
OPM17.69%2.24pp8.08pp
NPM10.86%1.78pp5.31pp
EPS2.3951.3%46.2%
View full financials

Revenue fell 9.5% YoY and adjusted PAT dropped 38.6% on sharp margin compression (OPM 25.8%→17.7%, NPM 16.2%→10.9%), a clear below-par quarter for an industrials name with no turnaround or one-off support.

Q1 FY-2027 RESULTS · KLBRENG-B

Kilburn Q1 FY27: consolidated PAT -39% YoY, revenue -9% as margins compress

PAT -38.57% YoY · revenue -9.48% · margins compressing

14 Aug 2026 · 3 min read
Revenue

₹116.99 Cr

-9.48% YoY

PAT (consolidated)

₹13.09 Cr

-38.57% YoY

Net margin

10.86%

-5.3pp YoY

EPS

₹2.39

Kilburn Engineering's consolidated revenue fell 9.5% YoY to ₹116.99 Cr (₹129.25 Cr in Q1 FY26) and 38.2% QoQ from a seasonally strong ₹189.18 Cr in Q4 FY26. Consolidated PAT dropped 38.6% YoY to ₹13.09 Cr (₹21.31 Cr) and 47.3% QoQ (₹24.86 Cr); EPS fell a steeper 46.2% YoY to ₹2.39 (₹4.44) since the equity base grew ~15.6% after warrant conversion. Standalone (parent-only) results were markedly weaker — revenue down 37.8% YoY to ₹58.90 Cr and PAT down 64.9% YoY to ₹5.17 Cr — so the group's smaller decline was driven almost entirely by the subsidiaries; the >3% standalone-consolidated divergence means readers should not read the standalone print in isolation.

The scoreboard

Q1 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q1 FY-2027QoQYoY
Revenue₹116.99 Cr-38.2%-9.5%
Expenses₹102.98 Cr-35.5%+0.8%
PAT₹13.09 Cr-47.34%-38.57%
Net margin10.86%-1.8pp-5.3pp
EPS₹2.39-51.3%-46.2%

Margins compressed on both counts: consolidated OPM (EBITDA/revenue) fell to 17.7% from 25.8% a year ago and 19.9% last quarter, while NPM slid to 10.9% from 16.2% YoY. The compression traces to operating deleverage on lower volumes — materials consumed rose to 48.5% of revenue from 41.6% YoY, and employee costs to 16.3% from 12.6% — rather than any one-off item; no exceptional items are disclosed in either statement. Management's own release, titled 'Revenue Down, Order Inflows Strong,' attributes the topline dip to 'near-term geopolitical uncertainties affecting the timing of customer decisions' rather than demand loss, and points to order momentum: the ₹70.2 Cr Casale order and fertilizer orders crossing ₹170 Cr booked in June 2026 sit in the order book but hadn't converted to Q1 billing.

339.74386.4433.05479.71526.36357.805-1106-0406-3007-2308-14Q1 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹357.8, down 20.1% over the past month of trading.

₹ Cr
010.0420.0730.1120.41Q4 FY25rev ₹127 Cr21.31Q1 FY26rev ₹129 Cr26.88Q2 FY26rev ₹154 Cr23.16Q3 FY26rev ₹157 Cr24.86Q4 FY26rev ₹189 Cr13.09Q1 FY27rev ₹117 Cr
Quarterly consolidated PAT, ₹ Crore
Beyond the headline

What the summary numbers don't show

Paid-up equity capital rose to ₹56.00 Cr from ₹52.96 Cr after conversion of 30.375 lakh warrants for ₹96.82 Cr; remaining 2.35 lakh warrants lapsed with ₹2.50 Cr forfeiture money retained

What management guided (4 FY-2026 call)
Management is targeting a top-line growth of 20% to 25% for the current financial year, aiming for revenues between INR750 crores to INR800 crores, and expects to maintain EBITDA margins above 20%, specifically targeting 22-23%. For the longer term, they are focused on achieving INR1,000 crores in revenue by FY28. Cape

This quarter: missed

There is no formal sell-side estimate on record for this print — Kilburn carries thin analyst coverage and no consensus figure was found — so vsStreet is unknown. Against management's own FY27 guidance from the Q4 FY26 call (20-25% revenue growth to ₹750-800 Cr, 22-23% EBITDA margin, capex expansions completing by Q2 FY27), this quarter's YoY revenue decline puts the company well behind the pace needed for the full-year target, even allowing that one quarter is not conclusive on its own. The quarter's other developments — designation of two Senior Management Personnel and a Monitoring Agency report for Q1 FY27 — are governance/compliance items with no direct bearing on the numbers.

  • W1

    Capex-driven capacity expansion targeted for completion by Q2 FY27 (per Q4 FY26 concall) — watch for ramp-up commentary at the Aug 17, 2026 earnings call

  • W2

    FY27 guidance of ₹750-800 Cr revenue (20-25% growth) now needs a much steeper ramp in the remaining nine months after Q1's 9.5% YoY decline — track whether the ₹70.2 Cr Casale and >₹170 Cr fertilizer orders convert to Q2 billing

  • W3

    OPM compressed to 17.7% from 25.8% YoY against management's 22-23% FY27 EBITDA margin target — watch for margin recovery as volumes normalize

Both statements clear/legible, tables tie out exactly (totalIncome and PBT-tax both match reported PAT). Standalone PAT fell far more (-64.9% YoY) than consolidated (-38.6% YoY) — subsidiaries (Monga Strayfield, Strayfield UK, M.E Energy, Kilburn East End) cushioned the group number. No exceptional items flagged; 30.375 lakh warrants converted to equity in the quarter for ₹96.82 Cr.

Informational and educational content only. Not investment advice.